CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3024% above fair value
$74.56+0.84 (+1.14%)
Close on Nov 17, 2026Market cap $3.92BP/E 31.2Yield –
CareDx operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CareDx's operating cash flow for the twelve months ending Sep 30, 2026 was $69.02M, up 62.2% year over year. For fiscal 2025 it was $42.03M, up 10.5% from the year before. The highest annual figure on record is $42.03M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.03M | +10.5% |
| FY2024 | Dec 31, 2024 | $38.05M | – |
| FY2023 | Dec 31, 2023 | -$18.39M | – |
| FY2022 | Dec 31, 2022 | -$25.24M | – |
| FY2021 | Dec 31, 2021 | -$19.29M | -157.7% |
| FY2020 | Dec 31, 2020 | $33.43M | – |
| FY2019 | Dec 31, 2019 | -$2.77M | – |
| FY2018 | Dec 31, 2018 | -$4.01M | – |
| FY2017 | Dec 31, 2017 | -$14.31M | – |
| FY2016 | Dec 31, 2016 | -$16.52M | – |
| FY2015 | Dec 31, 2015 | -$9.75M | – |
| FY2014 | Dec 31, 2014 | -$3.35M | – |
| FY2013 | Dec 31, 2013 | -$546.00K | – |
| FY2012 | Dec 31, 2012 | -$1.78M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $12.72M | -66.0% |
| Q2 FY2026 | Jun 30, 2026 | $30.60M | +209.3% |
| Q1 FY2026 | Mar 31, 2026 | $4.33M | – |
| Q4 FY2025 | Dec 31, 2025 | $21.36M | -2.4% |
| Q3 FY2025 | Sep 30, 2025 | $37.36M | +198.3% |
| Q2 FY2025 | Jun 30, 2025 | $9.90M | -47.8% |
| Q1 FY2025 | Mar 31, 2025 | -$26.58M | – |
| Q4 FY2024 | Dec 31, 2024 | $21.89M | – |
| Q3 FY2024 | Sep 30, 2024 | $12.52M | – |
| Q2 FY2024 | Jun 30, 2024 | $18.95M | – |
| Q1 FY2024 | Mar 31, 2024 | -$15.31M | -2382.0% |
| Q4 FY2023 | Dec 31, 2023 | -$8.38M | -216.6% |
| Q3 FY2023 | Sep 30, 2023 | -$10.18M | – |
| Q2 FY2023 | Jun 30, 2023 | -$499.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $671.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $7.19M | +72.5% |
| Q3 FY2022 | Sep 30, 2022 | -$7.08M | -1953.1% |
| Q2 FY2022 | Jun 30, 2022 | -$3.88M | -139.6% |
| Q1 FY2022 | Mar 31, 2022 | -$21.47M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.17M | -42.0% |
| Q3 FY2021 | Sep 30, 2021 | $382.00K | -92.7% |
| Q2 FY2021 | Jun 30, 2021 | $9.79M | -59.4% |
| Q1 FY2021 | Mar 31, 2021 | -$33.63M | – |
| Q4 FY2020 | Dec 31, 2020 | $7.18M | – |
| Q3 FY2020 | Sep 30, 2020 | $5.21M | +760.7% |
| Q2 FY2020 | Jun 30, 2020 | $24.10M | +573.9% |
| Q1 FY2020 | Mar 31, 2020 | -$3.06M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.08M | -154.2% |
| Q3 FY2019 | Sep 30, 2019 | $605.00K | +51.6% |
| Q2 FY2019 | Jun 30, 2019 | $3.58M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.87M | – |
| Q4 FY2018 | Dec 31, 2018 | $2.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $399.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.89M | – |
| Q1 FY2018 | Mar 31, 2018 | -$4.52M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.15M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.22M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.20M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.74M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.06M | – |
See a number that looks wrong?